TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21408161

Group type: EXPERIMENTAL
Intervention: N. americanus infection
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19248951

Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction (CAI) module
Number of subjects: 55

Group type: COMPARATOR
Intervention: Internet review articles
Number of subjects: 55
Study: 16838645

Group type: EXPERIMENTAL
Intervention: Interferon (IFN)‐alpha
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant interferon therapy
Number of subjects: 0
Study: 11494935

Group type: EXPERIMENTAL
Intervention: Antidepressant prescribing practices by nurse practitioners
Number of subjects: 0
Study: 9269644

Group type: EXPERIMENTAL
Intervention: Amino/Bic (1% amino acid, 34 mmol/l bicarbonate)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Glu/Bic (1.5% glucose, 34 mmol/l bicarbonate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glu/Lac (1.5% glucose, 35 mmol/l lactate)
Number of subjects: 10
Study: 8438972

Group type: EXPERIMENTAL
Intervention: Physician-led primary home care with a 24-hour service
Number of subjects: 183

Group type: COMPARATOR
Intervention: Ordinary care
Number of subjects: 183
Study: 3126508

Group type: EXPERIMENTAL
Intervention: 1 g l-carnitine (endovenous)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 29673934

Group type: EXPERIMENTAL
Intervention: Wedged footwear insoles
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Medial or lateral wedge footwear insoles
Number of subjects: 30
Study: 25985369

Group type: EXPERIMENTAL
Intervention: Heel raise inlay (ViscoHeel; Bauerfeind)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Physical therapy (eccentric exercise regime under physiotherapeutic supervision)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Wait and see protocol
Number of subjects: 101
Study: 25034509

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Rectal NSAID
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 151
Study: 22371837

Group type: EXPERIMENTAL
Intervention: 0.2% chloramine T
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1.0% chloramine T
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.01% fluorosurfactant
Number of subjects: 30

Group type: COMPARATOR
Intervention: Corega refreshing mint (control)
Number of subjects: 30
Study: 20376498

Group type: EXPERIMENTAL
Intervention: Lightweight mesh
Number of subjects: 50

Group type: COMPARATOR
Intervention: Heavyweight mesh
Number of subjects: 50
Study: 18695424

Group type: EXPERIMENTAL
Intervention: Cooled tip catheter
Number of subjects: 991

Group type: COMPARATOR
Intervention: 8-mm tip catheter
Number of subjects: 991
Study: 15970918

Group type: EXPERIMENTAL
Intervention: Around-the-clock (ATC) dosing of acetaminophen with codeine
Number of subjects: 80

Group type: COMPARATOR
Intervention: As-needed (PRN) dosing of acetaminophen with codeine
Number of subjects: 80
Study: 12775122

Group type: EXPERIMENTAL
Intervention: 10 g MCT (10M)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5 g MCT and 5 g LCT (5M5L)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5 g MCT in mayonnaise or margarine
Number of subjects: 16

Group type: COMPARATOR
Intervention: 10 g LCT (10L)
Number of subjects: 16
Study: 10512262

Group type: EXPERIMENTAL
Intervention: Educational videotape (19-min duration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no videotape)
Number of subjects: 100
Study: 7744189

Group type: EXPERIMENTAL
Intervention: Low-dose methylprednisolone (1 mg.kg‐1 q.d.)
Number of subjects: 47

Group type: COMPARATOR
Intervention: High-dose methylprednisolone (6 mg.kg‐1 q.d.)
Number of subjects: 47
Study: 16296709

Group type: EXPERIMENTAL
Intervention: Amlodipine 1.25 mg once daily
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Amlodipine 2.5 mg once daily
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg once daily
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg once daily
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 6125171

Group type: EXPERIMENTAL
Intervention: Metoprolol 150 mg twice daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pindolol 7.5 mg twice daily
Number of subjects: 10
Study: 30378136

Group type: EXPERIMENTAL
Intervention: Simulated fine fragrance containing Lim‐OOHs at 1260 ppm (3.0 μg/cm2)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Simulated fine fragrance containing Lim‐OOHs at 420 ppm (0.99 μg/cm2)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Simulated fine fragrance containing Lim‐OOHs at 140 ppm (0.33 μg/cm2)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Healthy controls exposed to the highest dose (1260 ppm)
Number of subjects: 28
Study: 30014863

Group type: COMPARATOR
Intervention: α-tocopherol (α-TF)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: tocotrienol rich fraction (TRF)
Number of subjects: 71
Study: 25527069

Group type: EXPERIMENTAL
Intervention: Two interventions, each of 1‐h duration, using behaviour change techniques (BCTs) including advocated attitude, anticipated success/regret, behaviour modelling and barrier identification
Number of subjects: 1830

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1830
Study: 25199060

Group type: EXPERIMENTAL
Intervention: Mepolizumab (100 mg)
Number of subjects: 135
Study: 21116607

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 0
Study: 19761925

Group type: EXPERIMENTAL
Intervention: Tripartite osteotomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bipartite osteotomy
Number of subjects: 50
Study: 17694911

Group type: EXPERIMENTAL
Intervention: Midazolam (benzodiazepine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study: 15177708

Group type: EXPERIMENTAL
Intervention: Dawn simulation (The Natural Alarm Clock, Outside In, Cambridge Ltd)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no dawn simulation)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dawn simulation
Number of subjects: 12
Study: 11474056

Group type: EXPERIMENTAL
Intervention: SACA - Parent Version
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SACA - administered to children aged 11 and older
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SACA - administered to children aged 9 and 10 years
Number of subjects: 0
Study: 9754744

Group type: EXPERIMENTAL
Intervention: Porcelain (P)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Indirect resin composite (IC)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Direct resin composite (DC)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Vital teeth
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Non-vital teeth
Number of subjects: 112
Study: 8000589

Group type: EXPERIMENTAL
Intervention: 19 mm or 21 mm St. Jude Medical prosthesis
Number of subjects: 80

Group type: COMPARATOR
Intervention: 23 mm or larger bileaflet prostheses
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 3396298

Group type: EXPERIMENTAL
Intervention: Etidronate
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Aminohexane diphosphonate
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Clodronate in hypoparathyroid patients
Number of subjects: 33
Study: 31495881

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg or 25 mg
Number of subjects: 7010

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7010
Study: 30581173

Group type: EXPERIMENTAL
Intervention: Co-developed intervention bundle
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 27183915

Group type: EXPERIMENTAL
Intervention: Ligation of the appendicular base with Lapro‐Clips (L‐C group)
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Ligation of the appendicular base with Hem‐o‐lok Clips (H‐C group)
Number of subjects: 1100
Study: 24355439

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Lactobacillus casei 01, 10^8 CFU daily for 8 weeks)
Number of subjects: 46
Study: 22536930

Group type: EXPERIMENTAL
Intervention: Antiretroviral treatment
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Both antiretroviral and antidepressant treatment
Number of subjects: 225

Group type: COMPARATOR
Intervention: Antiretroviral adherence
Number of subjects: 225

Group type: COMPARATOR
Intervention: Antidepressant adherence
Number of subjects: 225
Study: 20660052

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (25, 50, 125, 300, and 600 mg) administered weekly for 20 weeks
Number of subjects: 109
Study: 18337713

Group type: EXPERIMENTAL
Intervention: Strict blood pressure control and dietary protein restriction
Number of subjects: 1666
Study: 15735108

Group type: EXPERIMENTAL
Intervention: DMM (daily multiple micronutrient supplements)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: WMM (2 adequate intakes of multiple micronutrient on 1 day plus 6 days of placebo)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: DI (10 mg of iron supplement daily)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Placebo (daily placebo supplement)
Number of subjects: 284
Study: 12846338

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg once daily for 12 weeks
Number of subjects: 1719

Group type: COMPARATOR
Intervention: Placebo once daily for 12 weeks
Number of subjects: 1719
Study: 10228127

Group type: EXPERIMENTAL
Intervention: Inhaled leukotriene D4 (LTD4)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Allergen
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: LTD4
Number of subjects: 10
Study: 8689812

Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole orally once a day for 4 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2014978

Group type: EXPERIMENTAL
Intervention: Cephalosporin (various types)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Mezlocillin
Number of subjects: 108

Group type: COMPARATOR
Intervention: No antimicrobial agent (Control)
Number of subjects: 108
Study: 7138736

Group type: EXPERIMENTAL
Intervention: Tiaramide
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 30648627

Group type: EXPERIMENTAL
Intervention: oral ibandronate (150 mg)
Number of subjects: 171

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 171
Study: 29846623

Group type: EXPERIMENTAL
Intervention: Text messaging-based telemedicine intervention for IBD self-testing
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 193
Study: 26162422

Group type: EXPERIMENTAL
Intervention: Single-port TEP inguinal hernia repair
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional three-port TEP inguinal hernia repair
Number of subjects: 100
Study: 24286286

Group type: EXPERIMENTAL
Intervention: Polychromatic light treatment (611-650 nm or 570-850 nm, normalized to ∼ 9 J/cm²)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 136
Study: 22316322

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (energy‐ and protein‐enriched diet, oral nutritional supplements, calcium‐vitamin D supplement, telephone counseling by a dietitian) for 3 months after discharge
Number of subjects: 210

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Nutritional intervention
Number of subjects: 210
Study: 20565871

Group type: EXPERIMENTAL
Intervention: Injurious fall types classification based on location and activity
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Injurious fall types
Number of subjects: 333
Study: 17096462

Group type: EXPERIMENTAL
Intervention: MED + DBT
Number of subjects: 34

Group type: COMPARATOR
Intervention: MED
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: DBT + MED
Number of subjects: 34
Study: 15084372

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study: 12045414

Group type: EXPERIMENTAL
Intervention: Various controller medications for asthma treatment; specific medications and dosages not mentioned
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disease management and education programs; specific details not mentioned
Number of subjects: 0
Study: 9793771

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.50% timolol maleate
Number of subjects: 80

Group type: COMPARATOR
Intervention: 1% apraclonidine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.25% apraclonidine
Number of subjects: 80
Study: 8679050

Group type: EXPERIMENTAL
Intervention: Diapers
Number of subjects: 166

Group type: COMPARATOR
Intervention: Underpads
Number of subjects: 166
Study: 2617453

Group type: EXPERIMENTAL
Intervention: Nasal oxygen (2 litres/min)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 7
Study: 848586

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide (CDX) with water
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide (CDX) with Maalox
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo with Maalox
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo with water
Number of subjects: 10
Study: 30182319

Group type: EXPERIMENTAL
Intervention: Non-metallic staining/remineralization with sodium fluoride/AS
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Metallic staining/remineralization with silver diamine fluoride/AS
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: No staining/remineralization in artificial saliva (AS)
Number of subjects: 112

Group type: COMPARATOR
Intervention: No staining/no remineralization
Number of subjects: 112
Study: 28824315

Group type: EXPERIMENTAL
Intervention: Humidified heated breathing circuit (HHBC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional circuit
Number of subjects: 0
Study: 26636532

Group type: EXPERIMENTAL
Intervention: Eumastós (combination of boswellic acid, betaine, and myo-inositol)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 24180163

Group type: EXPERIMENTAL
Intervention: Ketamine (0.25 mg/kg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 66
Study: 21627429

Group type: EXPERIMENTAL
Intervention: Vicryl suture
Number of subjects: 132

Group type: COMPARATOR
Intervention: PDS suture
Number of subjects: 132
Study: 19804930

Group type: COMPARATOR
Intervention: External jugular vein catheterisation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Antecubital vein catheterisation
Number of subjects: 60
Study: 16316486

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 15894835

Group type: EXPERIMENTAL
Intervention: Mild aerobic exercise training (cycling on a leg ergometer at 80% ventilatory threshold for 30 min, 5 days/week) for 3 months
Number of subjects: 0
Study: 11747848

Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 113

Group type: COMPARATOR
Intervention: Nonhemodialysis
Number of subjects: 113
Study: 9296432

Group type: EXPERIMENTAL
Intervention: Inflated cuff insertion technique
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard uninflated approach
Number of subjects: 200
Study: 8405011

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg capsule) after 48 h abstention
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg capsule) after 12 h abstention
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo after 48 h abstention
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg capsule)
Number of subjects: 8
Study: 3950073

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg every 6 hours
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no cimetidine)
Number of subjects: 10
Study: 30059240

Group type: EXPERIMENTAL
Intervention: Virtual reality-based cue exposure therapy (VR-CET)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Additional cognitive behavioral therapy (A-CBT)
Number of subjects: 64
Study: 30405211

Group type: EXPERIMENTAL
Intervention: High CDA activity
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Low CDA activity
Number of subjects: 124
Study: 26825787

Group type: EXPERIMENTAL
Intervention: i-Factor Bone Graft
Number of subjects: 319

Group type: COMPARATOR
Intervention: Autograft
Number of subjects: 319
Study: 24393747

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 11752

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 11752

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 11752
Study: 23182011

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Sham Kinesio taping
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (no tape application)
Number of subjects: 61
Study: 20031461

Group type: EXPERIMENTAL
Intervention: Unilateral resistance training (RT: 3/week)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Electrical stimulation (ES: 1h/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Functional exercises (FE: 1h/day)
Number of subjects: 28
Study: 18094990

Group type: EXPERIMENTAL
Intervention: Oral antibiotic prophylaxis (gyrase inhibitor)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Intravenous antibiotic prophylaxis (gyrase inhibitor)
Number of subjects: 151
Study: 15933555

Group type: EXPERIMENTAL
Intervention: High dose HRV vaccine (10 focus-forming units)
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Low dose HRV vaccine (10 focus-forming units)
Number of subjects: 529

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 529
Study: 14569951

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg, increased to 100 mg if unsatisfactory response)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11452854

Group type: EXPERIMENTAL
Intervention: 10 mg of rt‐PA intraoperative injection into the opened basal subarachnoid cisterns following aneurysm clipping
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no rt‐PA treatment)
Number of subjects: 45
Study: 9347210

Group type: EXPERIMENTAL
Intervention: 60 micrograms ethinyl estradiol (EE) for 14 days followed by 40 micrograms EE plus 125 micrograms levonorgestrel (LNG) for 12 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned in the abstract)
Number of subjects: 21
Study: 8396707

Group type: EXPERIMENTAL
Intervention: NaHCO3
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 3510796

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI; n = 17)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 29
Study: 29449180

Group type: EXPERIMENTAL
Intervention: Family therapy
Number of subjects: 832

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 832
Study: 27373900

Group type: EXPERIMENTAL
Intervention: HPV 16/18 AS04-adjuvanted vaccine
Number of subjects: 4407

Group type: COMPARATOR
Intervention: Aluminium hydroxide control
Number of subjects: 4407
Study: 24238862

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose and maintenance dose for 6-24 hours, escalating doses: level 1 0.05 LD/MD, level 2 0.1 LD/MD, level 3 0.2 LD/MD)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 42
Study: 22420876

Group type: EXPERIMENTAL
Intervention: Digital Toothbrush System (DTS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control Group (COG)
Number of subjects: 21
Study: 19453623

Group type: EXPERIMENTAL
Intervention: Ketoconazole treatment (3 and 6 months)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ketoconazole treatment (6 months)
Number of subjects: 8
Study: 17394095

Group type: EXPERIMENTAL
Intervention: Stented group (60 patients)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Unstented group (60 patients)
Number of subjects: 120
Study: 16620253

Group type: EXPERIMENTAL
Intervention: Nipple shields
Number of subjects: 32
Study: 12514591

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) with foot compression at 80 mm Hg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) with calf compression at 40 mm Hg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) with calf + thigh compression
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) in the 15-degree head-down position
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) in horizontal and 15-degree head-up positions
Number of subjects: 12

Group type: COMPARATOR
Intervention: Simple elevation of the legs
Number of subjects: 12
Study: 10994312

Group type: EXPERIMENTAL
Intervention: Shared kangaroo care (holding all three infants at once)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Co-bedding the triplets in a single pediatric crib
Number of subjects: 1
Study: 8803897

Group type: EXPERIMENTAL
Intervention: Chloroquine diphosphate (CDP) 250 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 24
Study: 31325122

Group type: EXPERIMENTAL
Intervention: Active photobiomodulation (super‐pulsed laser 905 nm, red 640 nm, infrared 875 nm)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham photobiomodulation
Number of subjects: 30
Study: 30041682

Group type: EXPERIMENTAL
Intervention: Citrus aurantium + Caffeine (CA + C) (100 mg of CA and 100 mg of C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 10
Study: 26952348

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current standard of care
Number of subjects: 0